^
Association details:
| Biomarker: | LDH elevation + TP53 mutation |
|---|---|
| Cancer: | Diffuse Large B Cell Lymphoma |
| Regimen: | (cyclophosphamide + doxorubicin hydrochloride + prednisone + Rituxan (rituximab) + vincristine) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Aggressive Diffuse Intermediate Size B-Cell Lymphoma With P53 Mutation Presented as Primary Bone Marrow Lymphoma
Published date:
12/21/2020
Excerpt:
...PBML case represents a rare intermediate-sized B-cell, not typically recognized as DLBCL, with marked elevated LDH, more than 90% Ki-67 index, with P53 mutation, and showed no response to R-CHOP.
DOI:
10.1177%2F2324709620982765
